The a/fl T-cell receptor recognies a complex ligand formed by the association ofantigenic peptides with molecules ofthe major histocompatibility complex (MHC). The inherent limitations of the conventional T-cell activation assays used to detect these peptide/MHC ligands have, until now, hampered the development of expression cloning systems for T-cell antigens. To overcome these limitations, we have recently introduced a method for detecting ligand-induced activation of individual T cells. This assay, which makes use of a lacZ reporter construct, differs from conventional ligadinduced activation assays in that it allows the detection of single, activated T cells in large pools of resting cells. We applied the IacZ assay to the problem of screening expression libraries, which requires the ability to detect ligand-bearing antigen-presenting cells when they are present at very low frequency. We show here that ligand-expressing antigenpresenting cells can be detected at frequencies of 1:103-104, a level of sensitivity compatible with the screening of cDNA libraries. Furthermore, by using as antigen-presenting cells COS-7 cells stably transfected with the murine Kb class I MHC molecule, we demonstrate that transiently expressed ovalbumin is efficiently processed and presented to an ovalbumin/Kb_ specific T-cell hybridoma. IacZ expression is induced in a detectable number of cocultured T cells, even when the ovalbumin cDNA consists of only 1:104 of the total DNA used to transfect the COS cells. These results suggest that unknown T-cell antigens may be identified by screening cDNA libraries in MHC-expressing COS cells using lacZ-inducible T cells as indicators of peptide antigen expression.
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The a/X3 T-cell receptor (TCR) recognizes small antigenic peptides bound to major histocompatibility complex (MHC) molecules on the surface of antigen-presenting cells (APCs). For T cells of unknown specificity, especially those that cause tissue destruction in autoimmune diseases (1) , identifying the antigenic peptides remains a difficult undertaking. The primary reason for this difficulty lies in the inherent lack of sensitivity of the bulk T-cell activation assays used to detect peptide/MHC-expressing APCs. Because these assays measure only the average state of activation within a T-cell population, they cannot be used to detect activated T cells when these constitute only a small percentage of the T cells being assayed.
To overcome this obstacle, we have recently developed a method, the lacZ assay, for detecting the ligand-induced activation of single T cells (2) . The lacZ assay utilizes a reporter construct consisting of the bacterial (3-galactosidase gene (IacZ) under the transcriptional control of the nuclear factor of activated T cells (NF-AT) element of the human interleukin 2 (IL-2) enhancer (3, 4) . When this reporter construct is introduced into T-cell hybridomas, occupancy of the TCR triggers not only the secretion of IL-2 but also the production and intracellular accumulation of lacZ (2) . lacZ expression can be visualized by loading the T cells with either fluorogenic or chromogenic substrates (5, 6) . By using the lacZ assay, individual ligand-activated T cells can be readily detected, even when they comprise a very small fraction of the total T-cell population.
An important advantage of being able to detect small numbers ofactivated T cells is that it also allows the detection of correspondingly rare ligand-expressing APCs. This property of the lacZ assay suggested that lacZ-inducible T cells could be used to develop an expression cloning strategy for T-cell ligands. For such a strategy to be feasible, the lacZ assay had to be sensitive enough to detect antigen-expressing APCs at the low frequencies expected in the primary screen of an expression library.
To test whether the lacZ assay could be used for expression cloning of T-cell ligands, we developed a model system consisting of a lacZ-inducible T-cell hybrid specific for the ovalbumin (OVA)/Kb ligand and a COS cell line stably transfected with the Kb murine class I MHC molecule (Kb-COS). Transient Cell Lines. To facilitate the generation of lacZ-inducible T-cell hybrids, a lacZ-inducible derivative of BW5147 (Z.8) was made by transfecting the BW5147 cell line with the NFAT-lacZ reporter construct (3) using the methodology described previously (2) . The B3xZ. 
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The publication costs of this article were defrayed in part by page charge payment. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. §1734 solely to indicate this fact. generated by fusing Z.8 with B3, a Vs5-expressing cytotoxic T-cell clone specific for the OVA/Kb ligand (7) . The resulting hybridomas were screened for expression of the B3-derived TCR by staining with a Vp5-specific antibody (see below). To restore CD8 expression, which was extinguished in the T-cell hybrids, the V,5-expressing clones were transfected with a retroviral vector, kindly provided by D. Littman (University of California, San Francisco), containing the CD8a gene (8) . The V135+ CD8+ hybridomas were screened for OVA/Kb specificity in the 1L-2 and lacZ assays described below.
The K89-7.OVA cell line was generated, as described elsewhere, by transfecting a Kb-expressing subclone of the K89-7 L-cell line with the OVA cDNA (N.S., unpublished data).
The Kb-COS cells were obtained by stably transfecting the COS-7 cell line with a genomic clone of the murine Kb molecule (I 497) (9) , which was kindly provided by R. A. Flavell (Yale University School of Medicine). By using the calcium phosphate method (10), COS-7 cells were transfected with a total of 50 ,ug of DNA per 10-cm tissue culture dish: 40 ,ug of the Kb plasmid and 10 ,g of a coselection marker, the pMClneo-polyA+ plasmid (Stratagene). Transfectants were selected in 1 mg of G418 per ml (GIBCO/BRL). The G418-resistant cells were stained with an anti-Kb monoclonal antibody (see below) and Kb-expressing COS-7 cells were isolated by fluorescence-activated cell sorting (FACS).
Antibodies, Antigens, and Plasmids. The monoclonal antibodies 500A2 (anti-CD3e) (11), MR9-4 (anti-V135) (12) , 3 .155 (anti-CD8) (13), 28-13-3S (anti-Kb) (14) , and HK 2. The synthetic peptide analog of hen egg lysozyme (HEL) amino acids 74-88 (sequence: NH2-Asn-Leu-Ala-Asn-IlePro-Ala-Ser-Ala-Leu-Leu-Ser-Ser-Asp-Ile-OH) has been described (16) . Cyanogen bromide-digested OVA (CNBr OVA; grade IV Sigma) was prepared according to Moore et al. (17) .
The COS expression vector (pCDM8) (18) and plasmids containing the full-length OVA cDNA (pAc-Neo-OVA) (17) and the human CD3 ; chain (pCD30 (19) were kindly provided by B. Seed (Massachusetts General Hospital, Boston), M. Moore (University of Southern California Medical School, Los Angeles), and L. Lanier (Becton Dickinson), respectively. The pCDM8-OVA plasmid was constructed by first subcloning the OVA cDNA, a 1.8-kilobase (kb) EcoRI fragment, into the BlueScript(+) vector (Stratagene). Using flanking sites present in the BlueScript polylinker, the OVA cDNA was excised as a HindIII/Not I fragment and religated in the correct transcriptional orientation into the HindIII/Not I cloning sites of the pCDM8 vector.
T-Cell Activation Assays. lacZ/FDG assay. Individual cultures containing 5 x 105 APCs, 1 x 106 T cells, and the indicated concentration of antigen were set up in 24-well tissue culture plates (total volume = 1 ml per well). Cultures were incubated for 6 hr and then harvested for analysis by vigorous pipetting. To distinguish T cells from contaminating APCs, the samples were stained for Thyl with the monoclonal antibody HK2.1 (see above). The cells were then loaded with FDG (Molecular Probes) and analyzed for lacZ expression on a flow cytometer as described (2, 5) . Analysis was confined to the phycoerythrin-stained (Thyl positive) population, to exclude fibroblasts from the analysis. Cultures were incubated for 6 hr and then fixed and stained for lacZ expression with X-Gal (6). The plates were washed once with 0.1 ml of 10 mM phosphate-buffered saline (PBS) per well and then fixed for 5 min on ice with 0.1 ml of ice-cold 2% formaldehyde/0.2% gluteraldehyde in PBS per well. After another wash with 0.1 ml of PBS per well, the cells were overlaid with a solution of 1 mg of X-Gal per ml (Sigma), 5 Cytotoxic T cells, however, do not normally secrete IL-2 and were therefore not expected to induce the lacZ reporter construct, which is driven by the NF-AT element of the IL-2 gene. To overcome this limitation, we used a strategy developed earlier for generating IL-2-secreting, class I-restricted T-cell hybridomas (20, 21) . As detailed in Material and Methods, we generated somatic hybrids by fusing B3 (7) , an OVA/Kb-specific cytolytic T-cell clone, with Z.8, a derivative of BW5147 stably transfected with the NF-AT reporter construct. CD8 expression, which was absent in the T-cell hybrids, presumably due to fusion with the BW5147-derived fusion partner, was restored by infecting with a retroviral vector carrying the CD8a gene (8) . The level of TCR and CD8 expression on the surface of the transfected cells was determined by staining with monoclonal antibodies. As shown in the FACS profiles in Fig. 1A, (Fig. 1B) These results demonstrate that lacZ expression by B3Z is specifically induced by the OVA/Kb ligand. They also show that the NFAT-lacZ reporter construct can be used to measure activation of T-cell hybrids specific for MHC class I-and class II-bound peptides.
Microscopic Detection of lacZ+ T Cells by X-Gal Staining Increases the Sensitivity at Which Ligand-Expressing APCs Can Be Detected. The minimum number of lacZ1 T cells, and therefore the minimum number of ligand-expressing APCs, that can be detected by FDG staining is limited by the sensitivity of the FACS and the number of cells required for flow cytometry. In our hands, the limit of detection in a routine analysis (10,000-20,000 cells) is -3-5% lacZ+ cells. To develop a method suited to the analysis of a large number of samples, lacZ expression was visualized by staining the cocultured cells with X-Gal (6). X-Gal is cleaved by lacZ to yield 5,5'-dibromo-4,4'-dichloroindigo, which stains the lacZ-expressing cells dark blue.
The photomicrographs of X-Gal-stained samples shown in Fig. 2 cultures against the number of K89-7.OVA cells per well (Fig. 3) (Fig. 3) . The minimum frequency at which ligand-bearing cells can be detected appears to vary from one cell line to another. Significantly, MHC-expressing COS cells can function as very efficient APCs for murine T cells; in a limiting dilution analysis, OVA/Kb-expressing COS cells can be detected at a minimum frequency of 1 in 10,000 (Fig. 3) . EL-4 and other Kb-expressing cultured cell lines (data not shown). In the presence of CNBr OVA, the KbCOS cells were able to stimulate lacZ expression in B3Z cells (Fig. 2) The development of expression cloning systems for T-cell antigens has been hampered by the complexity of the TCR ligand. The generation ofthe peptide/MHC ligand in the APC is a complex and poorly understood process (reviewed in ref. 24) . The antigenic peptides are generated within the APC by proteolysis of native proteins and are subsequently presented on the cell surface as peptide/MHC complexes. Direct approaches for identifying individual antigenic peptides or their precursor proteins using conventional T-cell assays are difficult. The problem of obtaining micromolar quantities of rare proteins for performing T-cell stimulation assays is further compounded by the need to generate physiologically active peptide fragments. This difficulty can be partially circumvented by purifying naturally processed peptides directly from APCs (25) . Using HPLC technology, several abundant endogenous peptides have been successfully isolated and sequenced (26, 27) . How successfully this biochemical approach could be applied to antigenic peptides present in small amounts still remains to be established.
Kb-Transfected COS Cells Present Transiently Expressed
Expression cloning ofantigenic peptides is an alternative to biochemical purification strategies and is not dependent upon the total amount of peptide present, for as few as 100-500 peptide/MHC complexes are sufficient for stimulating a T cell (28, 29) . Not only does the expression cloning strategy proposed here obviate the need to purify relatively large quantities of protein or peptide, it is also less labor intensive and requires only commonly available equipment and reagents.
Expression cloning has been employed to identify genes encoding T-cell antigens on one previous occasion. Four tumor-specific ("tum-") antigens were identified by screening candidate APCs with antigen-specific cytotoxic T lymphocytes (30) . This accomplishment was particularly remarkable considering that a genomic cosmid DNA library was screened by generating several thousand stable transfectants, which were subsequently assayed by measuring their ability to induce proliferation of individual cytotoxic T lymphocyte clones. Our strategy differs from the one used to isolate the tum-antigens in several important respects. (i) By using a transient expression assay, candidate APCs can be generated and screened quickly (days versus weeks). (ii) Because the lacZ assay allows the screening of bulk cultures of APCs in which the frequency of ligand-expressing cells can be low (1:103), large numbers of candidate APCs can be screened with relatively little effort. (iii) By screening cDNA libraries rather than genomic libraries, the frequency of antigenencoding messages is expected to be higher. (iv) Our approach does not necessitate recloning of the desired gene from the genome of the ligand-expressing APCs. By using our proposed strategy, it should be possible to dramatically reduce the amount of time and labor required to screen a cDNA library and to increase the likelihood of finding antigen-coding sequences.
It should also be noted that the murine Kb-expressing COS cells can also serve as a model APC for the study of class I antigen presentation mechanisms. The ease with which expression constructs can be introduced into COS cells makes them an attractive alternative to the widely used vaccinia expression system (31) . Transient gene expression can be obtained in a large fraction (20-50%) of COS cells by direct transfer of expression vectors containing the SV40 replication origin, obviating the tedious requirement of constructing intermediate vaccinia recombinants. Also, exogenous gene expression in COS cells is less likely to be influenced by potentially complicating effects of the up to 200 other viral genes expressed by vaccinia recombinants (32) .
Finally, it is of obvious interest to determine if the lacZ/ COS cell system could also be adapted for use with class II-restricted T-cell antigens. Whether or not the COS cells can be induced to process and present endogenously expressed peptides on class II MHC remains to be established.
